European Commission Gives Green Light to Pfizer's PREVENAR 2

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active imm

Related Keywords

Brazil , Canada , Australia , Norway , Liechtenstein , Iceland , Lichtenstein , , Drug Administration , European Commission , Pfizer Inc , Pfizer , European Union , Alexandre De Germay , Chief International Commercial Officer , Executive Vice President , European Medicines Agency , Medicinal Products , Human Use ,